Harbour Investments’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Harbour Investments’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	–	–	3149
2022 Q3	$0	Hold	1,000	–	–	﹤0.01%	2887
2022 Q2	$0	Buy	+1,000	New	+$481	﹤0.01%	2887
2021 Q4	$2K	Sell	1,000 -475	-32%	-$1.44K	﹤0.01%	2459
2021 Q3	$6K	Buy	+1,475	New	+$7.59K	﹤0.01%	2947

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

Harbour Investments's SCPS Position: Q4 2022 in Review

Harbour Investments sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 1,000 shares.

Harbour Investments first reported a position in SCPS in Q3 2021 and held it in 4 quarters. The position peaked at $6K in Q3 2021. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

Harbour Investments reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Harbour Investments sold 1,000 Scopus BioPharma Inc. Common Stock shares in Q4 2022.
Harbour Investments first reported a position in Scopus BioPharma Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Harbour Investments's Scopus BioPharma Inc. Common Stock position peaked at $6K in Q3 2021.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on Harbour Investments's 13F filing for Q4 2022, filed 16 Feb 2023.